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Background
Changes in CSF circulation, as seen in adult chronic
hydrocephalus (CH), can result in changes in CSF con-
tent, neurodegeneration, a loss of neurological function,
and death. The microtubule-associated protein, Tau has
been implicated in the pathogenic mechanisms of demen-
tia and neurodegenerative disorders through accumula-
tion in CSF and brain. To date, the relationship between
the CSF circulation changes in CH and the levels of tau in
CSF and brain has not been studied.
Materials and Methods
This study used an experimental model of chronic
obstructive hydrocephalus developed in our laboratory to
investigate whether changes in CSF circulation could have
an effect on the level of Tau protein in CSF and brain. The
degree of CH-CSF impairment was determined on the
basis of changes in CSF volume, pressure and turnover.
CSF levels of Tau were quantified using standard ELISA
technique at baseline (pre-CH) and sacrifice (post-CH).
To determine the level of Tau protein in brain, immuno-
logical and histological methods were used to identify
neurons and glial cells, and stereologic cell counting pro-
cedure was used to determine the density of Tau+ cells in
the brain.
Results
Chronic hydrocephalus was surgically induced in 12 adult
male canines where the baseline levels of ICP (range 5–16
mmHg) and ratio of ventricle to brain (range 1.14–4.43 ×
103) increased 22.2% and 660% respectively. CH also
resulted in an average 22.9% decrease in the rate of CSF
clearance. In 8 of 12 cases the level of CSF Tau increased
an average 52.3%, however in 4 animals a decrease
(14.1%) was observed. Overall, the level of Tau in CSF did
not significantly correlate with changes in CSF volume,
pressure, or turnover. The density of Tau+ cells was
assessed in 7 animals (4 CH, 3 CTL) and was significantly
higher in the cortex of animals with CH lasting <30 days
(25%) and >30 days (18%) when compared to experi-
mental controls (P = 0.05). The density of Tau+ cells was
also higher in white matter for animals with CH (3–33%).
Conclusion
Our preliminary findings suggest that CSF circulation may
play a physiologically significant role in the pathophysiol-
ogy of Tau protein clearance, and in turn may influence
brain parenchymal tau levels. These results reinforce the
suggestion that Tau may play a role in the dementia of
chronic hydrocephalus as has been considered in other
dementias. Measures of Tau may be important in develop-
ing future diagnostic and/or treatment methods in CH.
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